medical report

Summary Doctor, Clinic LMU in Munich:

Currently, there is no study centre in Europe, where this therapy is carried out.

That’s why we ask for you to show your support in the effort for Nicolas treatment in a study centre in the USA. We were promised a place for him at Seattle, WE, Children’s Hospital from mid-February. There is a phase I / II study, which would take over the cost of the study drug and for the study procedures, but not for the general hospital costs. This would amount to US $ 187,000, which must be paid up in advance.  The treatment time would be approximately 2 months. Thank you for your support and let Nicolas partake in this for him potential life-saving therapy.”

 

PD Dr. M. Albert,
Director of the Stem Cell Transplant

 

LMU_seattle_1 LMU_seattle_2

pdf PDF LMU-MA-Arztschreiben

facebooktwittermail